subscribeSubscribe
U.S. Food and Drug Administration Issues Emergency Use Authorization for KINERET

U.S. Food and Drug Administration Issues Emergency Use Authorization for KINERET
GLOBENEWSWIRE
10 Nov 2022
Share Share
FDA signs off on Sobi`s Kineret for patients with pneumonia who are on oxygen

FDA signs off on Sobi`s Kineret for patients with pneumonia who are on oxygen
Kevin Dunleavy FIERCEPHARMA
10 Nov 2022
Share Share
EMA starts evaluating the use of Kineret in adult COVID-19 patients

EMA starts evaluating the use of Kineret in adult COVID-19 patients
EMA
19 Jul 2021
Share Share
NICE recommends Sobi’s Kineret for first-line use in Still’s disease

NICE recommends Sobi’s Kineret for first-line use in Still’s disease
Lucy Parsons PHARMATIMES
01 Apr 2021
Share Share
NICE Issues Positive Recommendation for Use of Kineret to Treat Still’s Disease

NICE Issues Positive Recommendation for Use of Kineret to Treat Still’s Disease
PHARMTECH
31 Mar 2021
Share Share
Kineret® (anakinra) approved in Russia for the treatment of CAPS

Kineret® (anakinra) approved in Russia for the treatment of CAPS
PRNEWSWIRE
16 Feb 2021
Share Share
FDA Approves KINERET® for the Treatment of Deficiency of IL-1 Receptor

FDA Approves KINERET® for the Treatment of Deficiency of IL-1 Receptor
GLOBENEWSWIRE
22 Dec 2020
Share Share
FDA Approves KINERET® (anakinra) for the Treatment of Deficiency of IL-1

FDA Approves KINERET® (anakinra) for the Treatment of Deficiency of IL-1
GLOBENEWSWIRE
22 Dec 2020
Share Share
Biovitrum`s Kineret (Anakinra) Receives Supplemental Approval in US

Biovitrum`s Kineret (Anakinra) Receives Supplemental Approval in US
FDA
22 Dec 2020
Share Share
Sobi launches Kineret for AOSD, SJIA

Sobi launches Kineret for AOSD, SJIA
Selina McKee PHARMA TIMES
17 Jul 2018
Share Share